Back
Norsk Hydro ASA Vs. Aligos Therapeutics Industry Stock Comparison
Sell
31
NHYDY
Norsk Hydro ASA
Last Price:
$5.48
Seasonality Move:
9.17%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
31
Norsk Hydro ASA (NHYDY)
is a Sell
Is Norsk Hydro ASA a Buy, Sell or Hold?
-
The current Norsk Hydro ASA [NHYDY] share price is $5.48. The Score for NHYDY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
NHYDY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NHYDY Stock Price Chart
What is Norsk Hydro ASA's stock price today?
-
The Norsk Hydro ASA share price today is $5.48Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NHYDY is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $41.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
NHYDY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 32.43 | Sell |
Chaikin Money Flow: | -30290 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.59 - 6.29) | Sell |
Bollinger Bands (100): | (5.47 - 6.33) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.69 | Buy |
Relative Strength Index (14 RSI): | 73.75 | Buy |
Chaikin Money Flow: | -154898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.72 - 37.64) | Buy |
Bollinger Bands (100): | (6.81 - 25.85) | Buy |
NHYDY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.51 | Sell |
20-day SMA: | 5.82 | Sell |
50-day SMA: | 6.07 | Sell |
200-day SMA: | 6.02 | Sell |
8-day EMA: | 5.56 | Sell |
20-day EMA: | 5.76 | Sell |
50-day EMA: | 5.94 | Sell |
200-day EMA: | 5.99 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.54 | Buy |
20-day SMA: | 33.12 | Buy |
50-day SMA: | 21.28 | Buy |
200-day SMA: | 16.61 | Buy |
8-day EMA: | 38.79 | Buy |
20-day EMA: | 33.47 | Buy |
50-day EMA: | 25.09 | Buy |
200-day EMA: | 18.34 | Buy |
Norsk Hydro ASA Earnings Growth & NHYDY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.20 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Norsk Hydro ASA Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |